SecBot SecBot
EFFECT ·Filed Mar 20, 2026

NERV

Minerva Neurosciences, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed7mo ago SEC9999999995-26-000876
IPO/offering going effective
Actionable Insight • Neutral

Monitor for imminent prospectus supplements that would disclose specific terms of any offering. Shelf registrations enable quick access to capital, which could lead to near-term dilutive equity sales.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
NERV ▼ -41.78% at T+60d
NEUTRAL call -41.78% · α vs SPY -56.20% · entry $7.54 → $4.39
Entry = T+0 close
Mar 20, 2026
via day close
T+1d
-13.13%
call -13.13% · α -14.23%
$6.55
settled 7mo ago
T+5d
-18.04%
call -18.04% · α -15.89%
$6.18
settled 7mo ago
T+20d
-8.62%
call -8.62% · α -17.94%
$6.89
settled 6mo ago
T+60d
-41.78%
call -41.78% · α -56.20%
$4.39
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Minerva Neurosciences' shelf registration (Form S-3) has become effective, allowing the company to issue unspecified securities from time to time. This creates potential for future dilution but does not specify the size, timing, or type of offering.

Key Facts

  • Form EFFECT filed for Minerva Neurosciences (NERV) indicates effectiveness of a shelf registration (S-3).
  • Effectiveness date: March 19, 2026.
  • SEC File Number: 333-294203.
  • The shelf registration allows the company to raise capital through unspecified offerings in the future.

Financial Impact

Unknown — no specific offering size or terms disclosed. Potential for future dilution.

dilutionequitycash

Risk Factors

  • Potential for unexpected equity issuance leading to share dilution.
  • Market perception of dilution overhang may pressure stock price preemptively.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000876
Document: 9999999995-26-000876-index.html9999999995-26-000876
Document: 9999999995-26-000876.txt9999999995-26-000876
9 reports for NERV
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NERV — sortable, filterable
TypeNow
Aug 12, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$3.92awaiting T+60—$2.30 (−41.33%)
Aug 7, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$4.27awaiting T+60—$2.30 (−46.14%)
May 27, 2026
21w ago
8-K
BEARISH ★ 6/10
$5.00 $4.84▲ +3.20%▲ +4.93%$2.30 (+54.00%)
May 5, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$6.25 $4.02▼ −35.68%▼ −38.42%$2.30 (−63.20%)
Apr 23, 2026
26w ago
DEFA14A
NEUTRAL ★ 4/10
$6.83 $4.37▼ −36.02%▼ −41.04%$2.30 (−66.33%)
Mar 25, 2026
30w ago
Press Release
NEUTRAL ★ 5/10
$6.14 $4.66▼ −24.10%▼ −38.05%$2.30 (−62.54%)
Mar 20, 2026
31w ago
EFFECT
NEUTRAL ★ 4/10
$7.54 $4.39▼ −41.78%▼ −56.20%$2.30 (−69.50%)
Mar 11, 2026
32w ago
S-3
BEARISH ★ 7/10
$7.30 $4.68▲ +35.89%▲ +47.41%$2.30 (+68.49%)
Mar 11, 2026
32w ago
Press Release
MIXED ★ 6/10
$7.30 $4.68▼ −35.89%▼ −47.41%$2.30 (−68.49%)
Showing 9 of 9

US Market Status

Market Closed — Opens Wed (12h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 20, 2026